Cargando…

The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity

The TAM receptors Tyro3, Axl, and Mertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands, Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells. In a form of apoptotic mimicry, many enveloped viruses display phosphatid...

Descripción completa

Detalles Bibliográficos
Autores principales: Miner, Jonathan J., Daniels, Brian P., Shrestha, Bimmi, Proenca-Modena, Jose L., Lew, Erin D., Lazear, Helen M., Gorman, Matthew J., Lemke, Greg, Klein, Robyn S., Diamond, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674389/
https://www.ncbi.nlm.nih.gov/pubmed/26523970
http://dx.doi.org/10.1038/nm.3974
_version_ 1782404891991343104
author Miner, Jonathan J.
Daniels, Brian P.
Shrestha, Bimmi
Proenca-Modena, Jose L.
Lew, Erin D.
Lazear, Helen M.
Gorman, Matthew J.
Lemke, Greg
Klein, Robyn S.
Diamond, Michael S.
author_facet Miner, Jonathan J.
Daniels, Brian P.
Shrestha, Bimmi
Proenca-Modena, Jose L.
Lew, Erin D.
Lazear, Helen M.
Gorman, Matthew J.
Lemke, Greg
Klein, Robyn S.
Diamond, Michael S.
author_sort Miner, Jonathan J.
collection PubMed
description The TAM receptors Tyro3, Axl, and Mertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands, Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells. In a form of apoptotic mimicry, many enveloped viruses display phosphatidylserine on the outer leaflet of their membranes, enabling TAM receptor activation and down-regulation of antiviral responses. Accordingly, we hypothesized that a deficiency of TAM receptors would enhance antiviral responses and protect against viral infection. Unexpectedly, mice lacking Mertk and/or Axl but not Tyro3 exhibited greater vulnerability to infection with neuroinvasive West Nile and La Crosse viruses. This phenotype was associated with increased blood-brain barrier permeability, which enhanced virus entry into and infection of the brain. Activation of Mertk synergized with IFN-β to tighten cell junctions and prevent virus transit across brain microvascular endothelial cells. Because TAM receptors restrict pathogenesis of neuroinvasive viruses, these findings have implications for TAM antagonists that are currently in clinical development.
format Online
Article
Text
id pubmed-4674389
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-46743892016-05-18 The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity Miner, Jonathan J. Daniels, Brian P. Shrestha, Bimmi Proenca-Modena, Jose L. Lew, Erin D. Lazear, Helen M. Gorman, Matthew J. Lemke, Greg Klein, Robyn S. Diamond, Michael S. Nat Med Article The TAM receptors Tyro3, Axl, and Mertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands, Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells. In a form of apoptotic mimicry, many enveloped viruses display phosphatidylserine on the outer leaflet of their membranes, enabling TAM receptor activation and down-regulation of antiviral responses. Accordingly, we hypothesized that a deficiency of TAM receptors would enhance antiviral responses and protect against viral infection. Unexpectedly, mice lacking Mertk and/or Axl but not Tyro3 exhibited greater vulnerability to infection with neuroinvasive West Nile and La Crosse viruses. This phenotype was associated with increased blood-brain barrier permeability, which enhanced virus entry into and infection of the brain. Activation of Mertk synergized with IFN-β to tighten cell junctions and prevent virus transit across brain microvascular endothelial cells. Because TAM receptors restrict pathogenesis of neuroinvasive viruses, these findings have implications for TAM antagonists that are currently in clinical development. 2015-11-02 2015-12 /pmc/articles/PMC4674389/ /pubmed/26523970 http://dx.doi.org/10.1038/nm.3974 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Miner, Jonathan J.
Daniels, Brian P.
Shrestha, Bimmi
Proenca-Modena, Jose L.
Lew, Erin D.
Lazear, Helen M.
Gorman, Matthew J.
Lemke, Greg
Klein, Robyn S.
Diamond, Michael S.
The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title_full The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title_fullStr The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title_full_unstemmed The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title_short The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
title_sort tam receptor mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674389/
https://www.ncbi.nlm.nih.gov/pubmed/26523970
http://dx.doi.org/10.1038/nm.3974
work_keys_str_mv AT minerjonathanj thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT danielsbrianp thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT shresthabimmi thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT proencamodenajosel thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lewerind thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lazearhelenm thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT gormanmatthewj thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lemkegreg thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT kleinrobyns thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT diamondmichaels thetamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT minerjonathanj tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT danielsbrianp tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT shresthabimmi tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT proencamodenajosel tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lewerind tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lazearhelenm tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT gormanmatthewj tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT lemkegreg tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT kleinrobyns tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity
AT diamondmichaels tamreceptormertkprotectsagainstneuroinvasiveviralinfectionbymaintainingbloodbrainbarrierintegrity